Trials https://www.nct-dresden.de/en/trials https://www.nct-dresden.de/@@site-logo/logo-nct.svg Trials PACE-LUNG DESTINY-Lung04 (AstraZeneca) nNGM PECa-Org Studie Hi-STEP1 Opposite II: REDESIGN BMS CA052-002 Janssen 75276617ALE1002 SoraTram MSC Imaging PALUGA HypoFocal SBRT Novartis DFV890 EORTC QoL FinTox therapeutisch: IMA402 (bispecific T cell engaging receptor molecule) AMG305_20220073 Poly-CR-P HEROES-AYA MESSAGE therapeutisch: BI 1438-0002 < Previous 20 items 1 2 3 4 5 6 7 ... 12 Next 20 items >
